NURS 6521 EXAM AND PRACTICE EXAM LATEST 2025

EXAM ELABORATIONS Aug 28, 2025
Loading...

Loading document viewer...

Page 0 of 0

Document Text

pg. 1

NURS 6521 EXAM AND PRACTICE EXAM LATEST 2025

ACTUAL EXAM TEST BANK| COMPLETE 300+

QUESTIONS AND CORRECT DETAILED ANSWERS

(VERIFIED ANSWERS) ALREADY GRADED A+|

ADVANCED PHARMACOLOGY FINAL 2025| BRAND

NEW!!

Which type of medication prescribed to a pregnant patient is more likely to have effects on the fetus?

  • Drugs that are highly polar
  • Ionized drugs
  • Lipid-soluble drugs
  • Protein-bound drugs - ANSWER - C
  • Lipid-soluble drugs cross the placenta more easily
  • Drugs that are highly polar, ionized, or are protein-bound will have
  • more difficulty crossing

A 5-year old child presents to your primary care clinic and has gray teeth. When taking a medication history, you will ask about previous use of which group of antibiotics?

A. PCN

  • Cephalosporins
  • Sulfonamides
  • Tetracyclines - ANSWER - D 1 / 4

pg. 2

  • Tetracyclines cause discoloration of developing teeth in children,
  • which is an adverse effect unique to this class of antibiotics

  • The other drugs listed here don't cause this effect

You are reviewing an older patient's chart during a routine clinic visit.Which patient information is of most concern to you if they are on multiple protein-bound medications?

  • Chronic constipation
  • ow serum albumin
  • Increased body fat
  • Low serum creatinine - ANSWER - B
  • Low serum albumin reduces protein binding of drugs & can cause
  • levels of free drug to rise, increasing risk of toxicity

  • The other options are not related to drug protein-binding

What term describes the drug level required for a medication to have a therapeutic effect in a patient?

  • Dynamic equilibrium
  • Critical concentration
  • Selective toxicity
  • Active transport - ANSWER - B
  • A critical concentration of a drug must be present before a reaction
  • occurs within the cells to bring about the desired therapeutic effect

  • Also known as "minimal effective concentration"
  • / 4

pg. 3 You have prescribed an IV aminoglycoside for a patient who has a severe infection in her leg. What would be important to monitor this patient for related to this class of antibiotics?

  • Renal dysfunction
  • Liver dysfunction
  • Serum glucose levels
  • Visual disturbances - ANSWER - A
  • When patients are taking aminoglycosides (i.e. gentamicin), they need
  • to be closely monitored for any signs of renal dysfunction

  • Usually we follow BUN/creatinine labs and urine output as clinical
  • indicators of worsening kidney function

You have recently graduated from an NP program and are exploring licensure in a variety of states. Prescribing authority is ...

  • determined by state law
  • the same for PAs and APRNs
  • the same in all states
  • regulated by the federal government - ANSWER - A
  • Individual states determine prescribing authority regulations, so you'll
  • need to check these in the state you want to practice in

  • The federal government isn't involved in this and there are definitely
  • differences between PA and APRN prescriptive authority laws

Which side effect of clindamycin causes the provider the most concern and may warrant discontinuation of the drug? 3 / 4

pg. 4

  • Diarrhea
  • Vomiting
  • Nausea

D. HA - ANSWER - A

  • Difficile-associated diarrhea (CDAD) is a serious and sometimes
  • life-threatening superinfection associated with clindamycin use

  • Typically, the drug is discontinued immediately, cultures are drawn,
  • and the C. Diff is treated if confirmed

A patient presents to the ER with a serum drug level of 50 g/mL. The half-life of this drug is 1 hour. With this drug, concentrations above 25 g/mL are considered toxic. How long will it take for the blood level to reach the non-toxic range?

  • 30 minutes
  • 1 hour
  • 2 hours
  • 3 hours - ANSWER - B
  • Half-life is the time required for the serum concentration of a drug to
  • reduce by 50%

  • After 1 hour, the serum concentration would be 25 g/mL (which is no
  • longer toxic)

You are treating a patient who has been receiving an IM drug, but will transition to the PO route upon discharge. What is responsible for the increased dosage prescribed for the PO dose of this drug?

  • / 4

Download Document

Buy This Document

$30.00 One-time purchase
Buy Now
  • Full access to this document
  • Download anytime
  • No expiration

Document Information

Category: EXAM ELABORATIONS
Added: Aug 28, 2025
Description:

pg. 1 NURS 6521 EXAM AND PRACTICE EXAM LATEST 2025 ACTUAL EXAM TEST BANK| COMPLETE 300+ QUESTIONS AND CORRECT DETAILED ANSWERS (VERIFIED ANSWERS) ALREADY GRADED A+| ADVANCED PHARMACOLOGY FINAL 2025...

Get this document $30.00